LifeStance Health Group, Inc. Common Stock
Here’s whether LifeStance Health Group, Inc. Common Stock (LFST) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.87% over 10 days); strong 1-year return of +56.8%; 3-month momentum positive (+31.8%). Concerns: declining volume on rally — weak conviction (0.53x 30d avg). Currently 4.4% off its 52-week high. Score: +5/7.
LFST is in a confirmed uptrend, trading above both its 50-day ($7.37) and 200-day ($6.57) moving averages. An RSI of 68.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +56.8% compares to +22.9% for SPY (beat the market by 34.0%).